Viva Voce Examination

This project aims to produce a useful, efficient resource for candidates preparing for viva voce examinations in a medical specialty.

This will include a brief overview of important lifestyle factors, anxiety management, and practical advice from previous candidates in several specialties, as assessed by a questionnaire.

We hypothesize that previous candidates may have valuable information and advice that may contribute to more strategic preparation and reduce anxiety for future candidates.

Before you decide whether or not you wish to participate in this study, it is important for you to understand why the research is being done and what it will involve. Please take the time to read the following information carefully and discuss it with others if you wish.


What is the purpose of this study?

The purpose of the study is to obtain information from previous viva voce candidates regarding their oral examination experience. The intent is to inform future candidates of the common experiences and advice provided, to encourage optimal exam preparation.

Why have I been invited to participate in this study?

You are eligible to participate in this study if you have undertaken oral examinations RACP, RACGP or RANZCR radiation oncology in the last 3 years.

What if I don't want to take part in this study or if I want to withdraw later?

Participation in this study is voluntary. It is completely up to you whether or not you participate.

New information about the experience of oral examination candidates may become published during the time frame of this study. You will not be kept informed of any significant new findings that may affect your willingness to continue in the study. If you wish to withdraw from the study once it has started, you can do so at any time without having to give a reason.

What does this study involve?

This study involves filling out a questionnaire once. This may take 5-10 minutes.

How is this study being paid for?

The study is being sponsored by the Radiation Oncology Private Practice Fund. Participation in this study will not cost you anything. Participants will not be paid for their involvement.

Are there risks to me in taking part in this study?

There is no risk of physical harm from participating in this study, and there will be no benefit for you.

What if something goes wrong?

There are no physical risks of participating in this study. Failing exams can be traumatic. If you feel distressed after answering the questionnaire, please contact your supervisor. You can also contact Lifeline on phone number 13 11 14.

Who is organising and funding the research?

This study is being conducted by the study team headed by Dr Hilde Kleiven. The study is being funded by The Canberra Hospital Radiation Oncology Private Practice Fund.

No investigator or member of research staff will receive a personal financial benefit from your involvement in this study. The study doctors declare no personal conflict of interest relevant to the undertaking of this study.

How will my confidentiality be protected?

Only the medical staff involved in this study may know whether or not you are participating in this study (and then only if the replies mentions your name or email address).

Identifying information is not sought. Any identifiable information that is collected about you in connection with this study will remain confidential and will be disclosed only with your permission, or except as required by law.

Only the researchers named above will have access to your details (if these are provided) and results that will be held securely at the Canberra Hospital in a locked office, with electronic data stored in password protected computers.

After the completion of the trial, all personal information will be deleted. If you have concerns about confidentiality, you may prefer to return the form by fax or mail.

What happens with the results?

Results aim to be published in a peer-reviewed medical journal.

In any publication, information will be provided in such a way that you cannot be identified.

What happens to my treatment when the study is finished?


What should I do if I want to discuss this study further before I decide?

When you have read this information, you may contact Dr Hilde Kleiven if you have any questions. You are also able to take this information away with you and discuss with your family, friends or any other person you choose.


Viva voce participant information sheet (November 2014)

Contact us

Phone: (02) 6244 2241


This study has been approved by the ACT Health Human Research Ethics Committee.

If you have any concerns or complaints about the conduct of this study, and do not feel comfortable discussing this with study staff, you may contact the Committee secretariat who is nominated to receive complaints about research projects.

You should contact the secretariat on (02) 6174 7968 or